Crystalline methamphetamine usage can wreak havoc in emergency departments
“Ice”, or crystalline methamphetamine, is a relatively new drug in Australia. It may be injected intravenously or swallowed, but is increasingly consumed by smoking. With about 1.8 million Australians (9%) reporting ever using methamphetamine and about half a million Australians aged 14 years and older (3.2%) reporting current use of the drug,1 Australia is among the top dozen countries in the world in terms of prevalence of methamphetamine use.2 However, its use varies considerably across the country, being higher in some states — such as Queensland (especially the Gold Coast region), South Australia and Western Australia3 — than others.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- St Vincent's Hospital, Sydney, NSW.
- 1. Australian Institute of Health and Welfare. 2004 National Drug Strategy household survey: detailed findings. Canberra: AIHW; 2005. (AIHW Cat. No. PHE 66; Drug Statistics Series No. 16.) http://www.aihw.gov.au/publications/phe/ndshsdf04/ndshsdf04.pdf (accessed Dec 2006).
- 2. United Nations Office on Drugs and Crime. 2006 World drug report. Vol 1: Analysis. Vienna: UNODC, 2006. http://www.unodc.org/pdf/WDR_2006/wdr2006_volume1.pdf (accessed Dec 2006).
- 3. Iverson J, Topp L, Maher L, et al. Drug use trends among injecting drug users: findings from the Australian Needle and Syringe Program Survey, 2001–2005. IDRS Drug Trends Bulletin Oct 2006. http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/Bulletins_2006/$file/IDRS+BULLETIN+OCT+2006.pdf (accessed Dec 2006).
- 4. McKetin R, McLaren J, Riddell S, Robins L. The relationship between methamphetamine use and violent behaviour. New South Wales Bureau of Crime Statistics and Research Crime and Justice Bulletin Aug 2006; No. 97. http://www.lawlink.nsw.gov.au/lawlink/bocsar/ll_bocsar.nsf/vwFiles/CJB97.pdf/$file/CJB97.pdf (accessed Dec 2006).
- 5. Australian Institute of Health and Welfare. AIHW National Hospital Morbidity Database. Separation, patient day and average length of stay statistics by principal diagnosis in ICD-10-AM, Australia, 1998–99 to 2003–04. http://www.aihw.gov.au/cognos/cgi-bin/ppdscgi.exe?DC=Q&E=/AHS/principaldiagnosis0304 (accessed Dec 2006).
- 6. Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust 2007; 186: 336-339. <MJA full text>
- 7. United Nations Office on Drugs and Crime. 2005 World drug report. Vienna: UNODC, 2005. http://www.unodc.org/unodc/world_drug_report_2005.html (accessed Dec 2006).
- 8. Prime Minister’s Strategy Unit, UK. Strategy Unit drugs report. Phase one — understanding the issues. May 2003. http://www.cabinetoffice.gov.uk/strategy/downloads/work_areas/drugs/drugs_report.pdf (accessed Dec 2006).
- 9. Grabowski J, Shearer J, Merrill J, Negus S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 2004; 29: 1439-1464.
- 10. Boyum D, Reuter P. An analytic assessment of US drug policy. Washington, DC: American Enterprise Institute for Public Policy Research, 2005. http://www.aei.org/books/bookID.812,filter.all/book_detail.asp (accessed Dec 2006).